MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
10.10
+0.29 (2.96%)
At close: Oct 31, 2025, 4:00 PM EDT
10.14
+0.04 (0.40%)
After-hours: Oct 31, 2025, 7:59 PM EDT
MLTX Market Cap
MLTX has a market cap or net worth of $641.36 million as of October 31, 2025. Its market cap has decreased by -79.24% in one year.
Market Cap
641.36M
Enterprise Value
292.05M
1-Year Change
-79.24%
Ranking
Category
Stock Price
$10.10
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $641.36M, an increase of 17,725.18%. That is a compound annual growth rate of 303.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 641.36M | -81.22% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |